4.06 USD
↘ 0.02 (0.37%)PRE MARKET (AS OF 07:01 AM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
Market: OPEN
Open?$4.04
High?$4.04
Low?$4.04
Prev. Close?$4.05
Volume?249
Avg. Volume?3.4M
VWAP?$4.04
Rel. Volume?0.00x
Bid / Ask
Bid?$3.99 × 100
Ask?$4.15 × 100
Spread?$0.16
Midpoint?$4.07
Valuation & Ratios
Market Cap?288.3M
Shares Out?71.2M
Float?46.7M
Float %?64.6%
P/E Ratio?N/A
P/B Ratio?1.58
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
288.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.19Strong
Quick Ratio?6.19Strong
Cash Ratio?0.91Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.58CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-68.0%WEAK▾
ROA?-49.1%WEAK▾
Cash Flow & Enterprise
FCF?$-125601000
Enterprise Value?$256.4M
Fundamentals ratios updated end of day